CN1472340A - Preparation method of biochip - Google Patents
Preparation method of biochip Download PDFInfo
- Publication number
- CN1472340A CN1472340A CNA021273359A CN02127335A CN1472340A CN 1472340 A CN1472340 A CN 1472340A CN A021273359 A CNA021273359 A CN A021273359A CN 02127335 A CN02127335 A CN 02127335A CN 1472340 A CN1472340 A CN 1472340A
- Authority
- CN
- China
- Prior art keywords
- biochip
- substrate
- hydrophobic
- preparation
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000018 DNA microarray Methods 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000000523 sample Substances 0.000 claims abstract description 40
- 238000000520 microinjection Methods 0.000 claims abstract description 32
- 239000000758 substrate Substances 0.000 claims abstract description 32
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 24
- 239000000126 substance Substances 0.000 claims abstract description 8
- 238000005507 spraying Methods 0.000 claims abstract 3
- 230000003100 immobilizing effect Effects 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 36
- 239000002773 nucleotide Substances 0.000 claims description 34
- 125000003729 nucleotide group Chemical group 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 25
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 108091034117 Oligonucleotide Proteins 0.000 claims description 20
- 125000000524 functional group Chemical group 0.000 claims description 15
- 239000007921 spray Substances 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 13
- 239000011521 glass Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- -1 polyethylene Polymers 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 239000004642 Polyimide Substances 0.000 claims description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 8
- 108010090804 Streptavidin Proteins 0.000 claims description 8
- 229920001721 polyimide Polymers 0.000 claims description 8
- 229910052710 silicon Inorganic materials 0.000 claims description 8
- 239000010703 silicon Substances 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 229920000515 polycarbonate Polymers 0.000 claims description 4
- 239000004417 polycarbonate Substances 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920000573 polyethylene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 239000004800 polyvinyl chloride Substances 0.000 claims description 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 3
- 239000007769 metal material Substances 0.000 claims description 3
- 239000010453 quartz Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 239000002210 silicon-based material Substances 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 claims 4
- 229920002477 rna polymer Polymers 0.000 claims 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 4
- 150000001412 amines Chemical class 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 229910010293 ceramic material Inorganic materials 0.000 claims 2
- 239000010445 mica Substances 0.000 claims 2
- 229910052618 mica group Inorganic materials 0.000 claims 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000002203 pretreatment Methods 0.000 claims 1
- 150000003377 silicon compounds Chemical class 0.000 claims 1
- 239000000428 dust Substances 0.000 description 27
- 238000002493 microarray Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 16
- 238000009736 wetting Methods 0.000 description 10
- 125000006239 protecting group Chemical group 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- 239000003929 acidic solution Substances 0.000 description 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000002444 silanisation Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RCHUVCPBWWSUMC-UHFFFAOYSA-N trichloro(octyl)silane Chemical compound CCCCCCCC[Si](Cl)(Cl)Cl RCHUVCPBWWSUMC-UHFFFAOYSA-N 0.000 description 2
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 2
- 239000005052 trichlorosilane Substances 0.000 description 2
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 2
- ZOGHLLHXZVKSQH-UHFFFAOYSA-N CP(O)N.P(=O)(NC)(N)N Chemical class CP(O)N.P(=O)(NC)(N)N ZOGHLLHXZVKSQH-UHFFFAOYSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical class COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- JHQYNYXQKSKNAK-UHFFFAOYSA-N OP(O)O.OP(O)O Chemical compound OP(O)O.OP(O)O JHQYNYXQKSKNAK-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- ARQRPTNYUOLOGH-UHFFFAOYSA-N chcl3 chloroform Chemical compound ClC(Cl)Cl.ClC(Cl)Cl ARQRPTNYUOLOGH-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000012779 flatbread Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- ZORAAXQLJQXLOD-UHFFFAOYSA-N phosphonamidous acid Chemical compound NPO ZORAAXQLJQXLOD-UHFFFAOYSA-N 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical class COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The invention provides a preparation method of a biochip, which comprises the following steps: spraying a hydrophobic substance on a substrate in a micro-injection manner to form a hydrophobic region on the surface of the substrate, and separating a plurality of cells by the hydrophobic region; and immobilizing a probe on the compartment by microinjection.
Description
Invention field
The present invention relates to a kind of preparation method of biochip; Particularly, relate to the preparation method who adopts the biochip that the microinjection mode makes.
Background of invention
Biochip is the breakthrough invention of twentieth century ultimogeniture thing science and technology the next item up, can match in excellence or beauty auto production line that Henry Ford then organized to the great revolution of automotive industry for the development of biotech industry, or similar semi-conductor is for the revolutionary character development of computer industry.In broad terms, biochip is meant on glass (glass), silicon chip (slica), plastics (plastic) or nitrocotton materials such as (nitrocellulose), utilize industrial technologies such as microelectronics, micromechanics, photoelectricity, automatization to make the product that is applied to biochemical analysis, its effective object can be gene, protein or cell tissue etc.The principal feature of biochip technology be analyze confidence level and tolerance range height, analysis speed is fast, employed sample and reagent are few, can handle a large amount of samples simultaneously, and obtain the experimental data of globality and parallelization.
On the whole, biochip research still belongs to the initial stage developmental stage in the world, but existing many great achievements.The kind of biochip has microarray (microarray), DNA wafer (DNAchip), protein/antibody wafer (protein/antibody chip), organizes wafer (tissue chip) and laboratory wafer (lab-on-a-chip) etc. at present, and is wherein comparatively ripe with microarray (microarray) and DNA wafer (DNA chip) development.And the purposes of biochip is very extensive, comprise application, the screening of medicine and the detecting of chemical and biological weapons etc. on gene sequencing, toxicological analysis, disease gene performance, the calibrating of single Yeast Nucleic Acid polymorphism, the medical jurisprudence, this shows that biochip must be the large flat bread that Mirae Corp. circle competitively strives food.But, how to grasp competitive edge and then depend on and prepare highdensity biochip how at lower cost.
Biochip can be divided into three kinds according to the mode difference of probe (probe) preparation, first kind of light guiding in-situ synthesis (light-directed synthesis) that the photo-engraving process (photolithography) that is Affymetrix company develops combines with chemical synthesis.Second kind is Stanford University's employed contact point sample method (pin), is to utilize in advance synthetic good DNA, RNA or protein with robotic arm fast, be fixed on the matrix to high-density.The third is microinjection (micro-injection method), utilizes microinjection (micro-injection) mode to remove to prepare complementary nucleotide as Rosetta Inpharmatics company.The interpretation mode of last data is that sample and wafer that desire detects are carried out hybridization (hybridization), again with the mark (label) on the subject matter in the sample (target), for example modes such as fluorescent, radiating material or ferment colour generation are carried out cat scanner and data analysis afterwards.
Making the common method of biochip at present may be: (a) utilize microarray point system machine that the synthetic probe solution is planted on the wafer by precise positioning mechanism cloth, or (b) utilize the technology of optical etching to carry out Nucleotide light direct in-situ synthesis method (light-directed in-situ synthesis).Wherein, carry the physical construction of probe solution can be divided into the syringe needle (pin) of contact and contactless micro-syringe (micro-injector) in the some system machine.The syringe needle of contact (pin) cost is low, but drop is bigger, array density lower (about 150~200 μ m of every bit), and destructible wafer surface; And contactless micro-syringe (micro-injector) can not destroyed wafer surface, and drop is less, array density higher (about 50~150 μ m of every bit).
For example, carry out the mode of light direct in-situ DNA synthesis method at glass surface with the technology that is derived from optical etching, can be at area 1.6cm
2The preparation kind on glass high-density micro-array of 400,000 kinds of nucleic acid probes nearly.Though be leading present technology, be subject to the too fast and light shield cost costliness of speed that the photochemical reaction rate is successively decreased according to the increase of nucleic acid probe length, so fail to popularize.Therefore, method commonly used at present is point-needle type (pin) and microinjection (micro-injection method), and wherein microinjection is divided into piezoelectric type microinjection and hot bubble type microinjection again.For example Protogene company utilizes piezoelectric type microinjection technology (piezo micro-injection, U.S.Pat.No.5985551; 6,177,558 B1) carry out DNA original position synthetic (DNA in-situ synthesis) in wafer surface, cost is lower, but density only is about 10~10
4Spots/cm
2
Though above-mentioned mentioned be that photo-engraving process, the some skill of handling needles or piezoelectric method all have its shortcoming, therefore with regard to the preparation of biochip, how preparing quality better, resolution, enough to reach low-cost biochip will be the main factor of winning victory.Prepare biochip in the microinjection mode and note the pollution to each other of probe drop.In order to overcome pollution problem, United States Patent (USP) the 5th, 552, disclosed for No. 270 with polyacrylamide colloid (polyacrylamide) and made many boothes, its colloidal thickness is 30 μ m, can prevent the mutual pollution of probe solution, and can increase probe solution fixed amount, so but shortcoming to be processing procedure trouble, cost high and because of moisture easily evaporation need be stored in the nonvolatile oil, therefore, need before using to clean with chloroform (chloroform) or ethanol (ethanol) again, generally speaking use and inconvenient.In addition, also can utilize the mode of conductor etching on silicon chip (silicon), to be etched into many sulculuses chamber and prevent pollution between probe solution, but this legal system journey trouble and spend high.The shortcoming of above-mentioned prior art promptly is the problem that institute of the present invention desire solves.
Summary of the invention
The purpose of this invention is to provide a kind of preparation method of simple and cheap biochip, it comprises the following steps: in the microinjection mode one lyophobic dust to be sprayed on the base material; Form a hydrophobicity district in this substrate surface, and be separated out a plurality of boothes by this hydrophobicity is trivial; And with the microinjection mode with a probe stationary on this booth.The inventive method not only can prevent between the probe drop interference phenomenon each other, also can increase the resolution of probe density and wafer.Therefore, the inventive method can be prepared high-density, drop is little, parsing power is good and cost is low biochip.
Description of drawings
Figure 1A to Figure 1B is sprayed on synoptic diagram base material on micro-syringe with lyophobic dust for showing the present invention.Figure 1A demonstration utilizes micro-syringe vertical direction to spray lyophobic dust to substrate surface; Figure 1B demonstration utilizes micro-syringe horizontal direction to spray lyophobic dust to substrate surface.
Fig. 2 A to Fig. 2 B shows that the present invention utilizes micro-syringe to spray lyophobic dust to substrate surface, forms the possible shape of booth at substrate surface.Fig. 2 A shows the quadrate booth; Fig. 2 B shows circular booth.
Fig. 3 shows the distribution of lyophobic dust on the substrate surface of the present invention and the sectional view that the probe drop covers situation.
After Fig. 4 A to Fig. 4 D showed the booth that the present invention separates out with lyophobic dust, the fixed nucleic acid probe was to the synoptic diagram of base material.Fig. 4 A demonstration splashes into different booth (wetting ability district) with the Nucleotide solution that micro-syringe will have protecting group; Fig. 4 B demonstration is removed protecting group with acidic solution; Fig. 4 C demonstration splashes into different booth (wetting ability district) with micro-syringe with the Nucleotide solution that the 2nd floor has protecting group; And Fig. 4 D shows the biochip that preparation is finished.
Fig. 5 is the structural map of the hot bubble type micro-syringe that adopts of most preferred embodiment of the present invention.
Fig. 6 A-Fig. 6 D is the operation chart of the micro-syringe of Fig. 5, Fig. 6 A is the cross-sectional view of micro-syringe, Fig. 6 B is for forming the situation of first bubble, Fig. 6 C is for then forming second bubble, make two bubble incorporation and extrude the situation of drop, Fig. 6 D is that two bubble collapses make unnecessary liquid flow back to the situation of liquid tank.
Embodiment
The invention provides a kind of preparation method of biochip, at first one lyophobic dust is sprayed on the base material, form a hydrophobicity district, and separate out a plurality of boothes by this lyophobic dust in this substrate surface in the microinjection mode.Then, again with the microinjection mode with a probe stationary in each booth.
Usually the material that can be used as the biochip base material can be hydrophobic substrates or hydrophilic base.Hydrophobic substrates includes but not limited to following material--glass, silicon chip, plastic cement, nylon membrane, resin, quartz, pottery and metal material.Hydrophilic base then mostly is polymkeric substance, comprise as polystyrene (polystyrene), polyester (polyester), polycarbonate (polycarbonate), polyvinyl chloride (polyvinylchloride), polyethylene (polyethylene), polypropylene (polypropylene), polysulfones (polysulfone), polyurethane(s) (polyurethane) or poly-basic methyl acrylate materials such as (PMMA), but be not limited thereto the place person of enumerating.
If adopt hydrophobic substrates, then when having sprayed lyophobic dust after, the booth surface that the hydrophobicity district of lyophobic dust formation is separated out, must be processed into possess hydrophilic property functional group earlier could combine with probe.The hydrophilic functional group of indication can be amido (NH herein
2), carboxyl (COOH), thiol (SH), epoxy group(ing) (epoxide), aldehyde radical (aldehyde) or streptavidin (Streptavidin) etc.
If the employing hydrophilic base then needs earlier surface treatment to be become hydrophobicity, could spray lyophobic dust then, to form the hydrophobicity district.Afterwards, need again booth to be processed into wetting ability, could combine with probe.The substrate surface modifying method can be with reference to following paper: Souther, Chem.abst.113; 152979r (1990) and Anal.Biochem.157; 283 (1986), do not repeat them here.
Microinjection mode of the present invention is to adopt a micro-syringe (micro-injector), with vertical, level or any direction, unidirectionally or two-way sprays back and forth, as shown in Figure 1A and Figure 1B.The micro-syringe that is adopted comprises hot bubble type micro-syringe and piezoelectric type micro-syringe.The hot bubble type micro-syringe that is adopted comprises: a groove chamber, in order to place liquid; One microinjection hole is positioned on the groove chamber, and the liquid in the groove chamber is flowed out; And a primary heater and a secondary heater, be arranged in the both sides in this microinjection hole respectively.When the filled with fluid of groove chamber, primary heater can produce first bubble, and then, secondary heater can produce second bubble, utilizes two bubbles that liquid is cut off ejection, and primary heater and secondary heater are driven by a common signal.In addition, the generation of first bubble is as a valve, and the liquid that limits in this groove chamber flows out, and hereinafter will describe in detail.
The lyophobic dust that the present invention sprays in the microinjection mode includes, but not limited to tetrafluoroethylene (Teflon), polyimide (polyimide), siliceous and fluorine-containing water-sprinkling agent and fluorine-containing and silicon-containing compound etc.After being sprayed to lyophobic dust on the base material, lyophobic dust can form hydrophobic region at substrate surface, separates out a plurality of boothes by hydrophobic region, and booth can be for square, circular or any geometricdrawing, shown in Fig. 2 A and Fig. 2 B.The booth magnitude range can be 20~200 μ m, and the thickness range of lyophobic dust can be 1~30 μ m, and width range can be 5~100 μ m.
As shown in Figure 3, the form of desiring to be fixed in probe on the substrate surface and being with drop is sprayed out by micro-syringe, covers in the booth (wetting ability district).Probe solution is housed in the micro-syringe, this probe solution can be thymus nucleic acid (DNA), Yeast Nucleic Acid (RNA), Nucleotide (Nucleotides), oligonucleotide (Oligonucleotides), protein (Protein), antibody (Antibodies) or peptide (Peptides) etc., but is not limited to the above person of enumerating.Above-mentioned probe stationary is to reach via the mode of a functional groups in the method for booth, and the functional groups mode comprises absorption (adsorption) method, covalent attachment method (covalent binding), coating method (encapsulation), crosslinking (cross-linking) and entrapping method (entrapment) etc., but is not limited to aforesaid method.If common probe solution DNA; when RNA or Nucleotide; must be earlier make that through some chemically modifieds the functional groups on itself and the substrate surface is tightr; for example be modified into phosphonate (phosphonate); phosphonic acids hydrogen salt (hydrogen phosphonate); phosphoramide (phosphonamidite); phosphoramidite (phosphoramidite); phosphite (phosphite) or methyl phosphoramide (methylphosphonamidite) compounds; if preparation oligonucleotide microarray (oligonucleotide microarray), in 5 of Nucleotide ' or 3 ' end must connect protecting group and combine with the Nucleotide that prevents same layer.
Produce the little microarray biochip of drop, wherein the size in the surface tension of Nucleotide solution itself, viscosity and microinjection hole is the major decision factor, and usually general drop size is about 25~250 μ m.
If prepare the Nucleotide microarray, then must more consider the viscosity of choice of Solvent in the Nucleotide solution and solvent with the hot bubble type micro-syringe.In general, therefore the drop little then more easily volatilization of healing, must contain a kind of high boiling solvent in the common employed solvent at least, and for example boiling point prevents the volatilization of nucleic acid solution greater than 140 ℃ solvent.Selected solvent is comparatively suitable with polar aprotic solvent, commonly used just like two nitriles (dinitriles), mononitriles (mononitriles), glyme class (glymes), diethylene glycol diformazan ethers (diglymes), triglyme class (triglymes), trimethyl phosphate (trimethylphosphates), dimethyl formamide (dimethylformamides, DMF) and N-Methyl pyrrolidone (N-methyl pyrrolidinone, NMP) etc.
When preparation oligonucleotide microarray (oligonucleotide microarray) wafer; utilize micro-syringe that each shielded Nucleotide (protected nucleotides) is fixed on the base material in order just like the mode of piling up wood, the protecting group that connects on Nucleotide is to be used for preventing the Nucleotide of each layer to overlap each other together.After the Nucleotide solution of the first layer fixedly gets on; utilize acidic solution that the protecting group on the Nucleotide is removed; and then the fixing Nucleotide of going up the second layer, can prepare desired biochip apace by that analogy, this kind method is more flexible in the design of nucleotide probe.If when preparation DNA, RNA or protein chip, then directly will synthesize good thymus nucleic acid (DNA), Yeast Nucleic Acid (RNA) or protein and directly be sprayed in the booth of base material.Then peptide is connected one by one during preparation peptide (peptides) wafer as the Nucleotide micro-array.
Sample and the above-mentioned biochip for preparing that desire is detected carries out hybridization (hybridization) at last, carry out differential responses by the mark (label) on the subject matter in the sample (target) more afterwards, for example modes such as fluorescent, radiating material, ferment colour generation are carried out cat scanner and data analysis.
Embodiment
Below will specify the present invention with embodiment, right category of the present invention is not limited to the scope shown in the embodiment.
1: the first kind of preparation method who carries out batch oligonucleotide microarray (oligonucleotide microarray) with the hot bubble type micro-syringe of embodiment.
1. the glass surface with micro-syringe forms booth
With glass is base material, and lyophobic dust to contain lyophobic dust, directly, regularly sprays as the hot bubble type micro-syringe of teflon (Teflon) at glass surface in elder generation, to form the square booth that lyophobic dust separates, shown in Fig. 2 A.The width range of its intermediate chamber is about 50 μ m, and the thickness that lyophobic dust sprays is 2 μ m, and width is 5 μ m.
2. carrying out wetting ability in booth handles
In the square booth that hydrophobicity separates out, to contain the micro-syringe of octyl group trichlorosilane (octyltrichlorosilane), carrying out silanization (silanization) handles, make the booth zone become the wetting ability district, its surface has thiol and (SH) is able to combine with nucleotide probe detailed method such as United States Patent (USP) the 6th, 159, No. 695, can form a nonvolatil thioether bond or the reversible cystine linkage of a chemistry selection thiol key to surface, wetting ability district.
3. oligonucleotide is incorporated on the microarray sheet
The dimethoxy tribenzyl Nucleotide phosphamic acid solution (DMTr-nucleotide phosphoramidite) that will contain tetrazolium (tetrazole) activator is sprayed in the wetting ability district that silanization has been handled with micro-syringe, and the first layer Nucleotide can (SH) combine with the thiol in the wetting ability district.Utilize acidic solution then, protecting group is removed, spray second layer Nucleotide again as Tricholroacetic Acid (trichloroacetic acid) or hydrochloric acid (HCl) solution.Connect each Nucleotide successively with said procedure, can obtain oligonucleotide microarray (oligonucleotide microarray) at last, detailed steps can be with reference to United States Patent (USP) the 6th, 184,347B1 number, the 5th, 985, No. 551, does not repeat them here.
4. carry out hybridization (hybridization) with the oligonucleotide microarray that obtains
Target nucleotide sequence (target) that desire is detected and above-mentioned oligonucleotide microarray carry out hybridization at last, then by the mark (Label) on the target Nucleotide (target), what the sequence that can learn target Nucleotide (target) is, way can be with reference to United States Patent (USP) the 5th in detail, 985, No. 551.
The preparation method of 2: the second kinds of batch oligonucleotide microarrays of embodiment.
The compartment shape of oligonucleotide microarray (oligonucleotide microarray) can also be circle, shown in Fig. 2 B.Can directly spray lyophobic dust and form circular compartment with micro-syringe.Or doing a corresponding circular slab earlier covers on the base material, sprays lyophobic dust with micro-syringe then, takes away circular slab subsequently, can obtain circular compartment at last.Wherein the circular slab material is good with hydroaropic substance, for example nylon membrane etc.Preparation process afterwards is identical with embodiment 1.
Embodiment 3: the preparation method who carries out protein chip (Protein chip) with the piezoelectric type micro-syringe.
1. form the hydrophobicity compartment with micro-syringe at glass surface
With glass is base material, earlier at glass surface to contain lyophobic dust, as polyimide (polyimide), the piezoelectric type micro-syringe spray lyophobic dust directly, regularly, in order to form square hydrophobicity compartment, shown in Fig. 2 A, the width range of its intermediate chamber is about 50 μ m, and the thickness that lyophobic dust sprays is 2 μ m, and width is 5 μ m.
2. make protein bound on the microarray sheet
With octyl group trichlorosilane (octyltrichlorosilane), make square booth finishing that lyophobic dust is separated out become to have thiol and (SH), make that protein probe can be in conjunction with thereon.The combining method of protein probe and base material can be with reference to United States Patent (USP) the 6th, 225,047 B1 number, does not repeat them here.
3. detect the proteic test of target with protein chip
After above-mentioned protein chip prepared, in the booth on protein example (sample) the adding wafer, (Cy3 Cy5) can learn to contain which kind of protein in the sample by the fluorescent subject matter on the sample.
Though the present invention is described with preferred embodiment; right its is not in order to limit the present invention; those of ordinary skill in the art is familiar with this skill person; do not breaking away under the spirit and scope of the present invention; can do various changes and modification, so protection scope of the present invention is as the criterion with the scope of claims.
For above-mentioned and other purposes of the present invention, feature and advantage can be become apparent, hereinafter, be described in detail below by preferred embodiment and in conjunction with appended diagram:
The explanation of symbol
The symbol of Fig. 1-4D:
10~micro-syringe;
12~lyophobic dust;
14~micro-syringe moving direction;
16~base material;
18~hydrophobicity district;
20~booth;
21~wetting ability district;
22~nucleic acid drop;
24~have a Nucleotide drop of protecting group;
26~protecting group;
28~acidic solution;
The symbol of Fig. 5-6D:
1~jet orifice;
2~primary heater;
3~secondary heater;
4~electrode;
5~groove chamber;
6~microchannel;
7~liquid;
8~wafer;
A~first bubble;
B~second bubble;
P~bubble direction of expansion;
F~drop emission direction.
Claims (28)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02127335 CN1239714C (en) | 2002-08-02 | 2002-08-02 | A kind of preparation method of biochip |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02127335 CN1239714C (en) | 2002-08-02 | 2002-08-02 | A kind of preparation method of biochip |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1472340A true CN1472340A (en) | 2004-02-04 |
CN1239714C CN1239714C (en) | 2006-02-01 |
Family
ID=34143508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02127335 Expired - Fee Related CN1239714C (en) | 2002-08-02 | 2002-08-02 | A kind of preparation method of biochip |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1239714C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102692515B (en) * | 2011-03-23 | 2014-09-17 | 成功大学 | Biomedical chip used for blood coagulation tests, its manufacturing method and application |
TWI636244B (en) * | 2017-03-24 | 2018-09-21 | 國立清華大學 | Manufacturing device and manufacturing method for test strips |
-
2002
- 2002-08-02 CN CN 02127335 patent/CN1239714C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1239714C (en) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6268210B1 (en) | Sandwich arrays of biological compounds | |
EP0804731B1 (en) | Method and apparatus for fabricating microarrays of biological samples | |
EP1451584B1 (en) | High surface area substrates for microarrays and methods to make same | |
US6589726B1 (en) | Method and apparatus for in situ synthesis on a solid support | |
US5763263A (en) | Method and apparatus for producing position addressable combinatorial libraries | |
US6309828B1 (en) | Method and apparatus for fabricating replicate arrays of nucleic acid molecules | |
CN1232343C (en) | Devices and methods for carrying out chemical reactions using photogenerated reagents | |
EP1180170A4 (en) | POLYNUCLEOTID ARRAYS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
EP1643249A1 (en) | Bio-chip | |
CN1388797A (en) | Method for obtaining a surface activation of a solid support for building biochips microarrays | |
CN100350249C (en) | Interaction detecting method and bioassay device, and bioassay-use substrate | |
EP1618382A1 (en) | Improved composite microarry slides | |
JP2006519285A (en) | Systems and methods for polymer synthesis | |
CN1109757C (en) | Compound micro path array chip and its preparing method | |
US6903177B2 (en) | Oligomer for immobilizing physiological material, and composition for immobilizing physiological material comprising the same | |
EP1660228A1 (en) | Microarray support for bioprobe synthesis | |
CN1472340A (en) | Preparation method of biochip | |
JP2001128683A (en) | Method for fixing dna fragment and method for detecting dna chip and nucleic acid fragment | |
US20030068621A1 (en) | Method and device for producing oligonucleotide arrays | |
CN1159454C (en) | Compound micro-array chip preparing process and the micro-array chip using the same | |
CN1651580A (en) | Patch for microarray reaction chamber having adhesive means support and two or more adhesive materials | |
JP2002286736A (en) | Method of manufacturing probe carrier and device of manufacturing probe carrier | |
CN1194101C (en) | Plastic substrate useful for making bio-chip | |
US20040018614A1 (en) | Biochip preparation method | |
Tang et al. | In situ synthesis of DNA micro-arrays using typography technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |